Merkel cell carcinoma in a patient with  GATA 2 deficiency: a novel association with primary immunodeficiency | Zendy

Crall C. | Zendy; Morley K.W. | Zendy; Rabinowits G. | Zendy; Schmidt B. | Zendy; Broyles A. Dioun | Zendy; Huang J.T. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Merkel cell carcinoma in a patient with GATA 2 deficiency: a novel association with primary immunodeficiency

Author(s) -

Crall C.,

Morley K.W.,

Rabinowits G.,

Schmidt B.,

Broyles A. Dioun,

Huang J.T.

Publication year - 2016

Publication title -

british journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.304

H-Index - 179

eISSN - 1365-2133

pISSN - 0007-0963

DOI - 10.1111/bjd.14062

Subject(s) - merkel cell carcinoma , primary immunodeficiency , immunodeficiency , immunosuppression , neurofibromatosis , medicine , merkel cell polyomavirus , immunologic deficiency syndromes , malignancy , immunology , dermatology , carcinoma , pathology , immune system

Summary A 55‐year‐old woman with GATA 2 deficiency and neurofibromatosis 1 was diagnosed with Merkel cell carcinoma ( MCC ). This polyomavirus‐associated cutaneous malignancy has previously been associated with immunosuppression and acquired immunodeficiencies such as HIV / AIDS . However, MCC has not been previously reported in the setting of underlying primary or inherited immunodeficiency.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research